MaxCyte, Inc. Announces Gram-Scale Antibody & Protein Production from the Transient Transfection of CHO Cells

GAITHERSBURG, Md.--(BUSINESS WIRE)--MaxCyte, Inc., the pioneer in scalable, high performance cell loading systems, announces the production of gram-scale quantities of proteins and antibodies from CHO cells using the MaxCyte® STX™ Scalable Transfection System. The MaxCyte STX has the capability to transfect from 5E5 to 1E10 cells with comparable results from small bench scale through screening and cGMP manufacturing. Recent results from MaxCyte STX users demonstrate the potential to achieve gram-scale antibody and protein production in an appropriate biomanufacturing host cell line with a simple 20-30 minute transfection run.